Cue Biopharma (CUE) Other Non Operating Income (2018 - 2020)

Cue Biopharma has disclosed Other Non Operating Income across 3 years of filings, most recently posting -$23000.0 for Q3 2020.

• Other Non Operating Income for Q3 2020 came in at -$23000.0, down 560.0% year-over-year; the trailing twelve-month figure through Sep 2020 was -$56922.0 (down 139.71% YoY), and the FY2019 annual result was $64078.0, down 61.24% from the prior year.
• Other Non Operating Income came in at -$23000.0 for Q3 2020 at Cue Biopharma, up from -$26000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $98000.0 in Q3 2018 to a low of -$26000.0 in Q1 2020.
• The 3-year median for Other Non Operating Income is $3500.0 (2018), against an average of $18041.5.
• Across the five-year window, Other Non Operating Income soared 4700.0% in 2019 and plunged 560.0% in 2020, its largest moves.
• Cue Biopharma's Other Non Operating Income stood at $66337.0 in 2018, then plunged by 119.48% to -$12922.0 in 2019, then plunged by 77.99% to -$23000.0 in 2020.
• The last three Other Non Operating Income figures came in at -$23000.0 (Q3 2020), -$26000.0 (Q1 2020), and -$12922.0 (Q4 2019), per Business Quant data.